S 4327 119th Congress
A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
![Sen. Cotton, Tom [R-AR]](https://bioguide.congress.gov/bioguide/photo/C/C001095.jpg)
Actions
2026-04-16T00:00:00
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2026-04-16T00:00:00
Introduced in Senate
Track this bill on CivicBeacon
Get push notifications when this bill is updated, contact your reps, and take action.
